Solara Active Pharma Sciences Results Update

Solara Active Pharma Sciences Other Announcement

Solara Active Pharma Sciences Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This disclosure details equity ownership across various investor categories.

Solara Active Pharma Sciences Earnings Call Transcript: Key Takeaways

Solara delivered its best profitability in five years despite ongoing Ibuprofen pricing and raw material challenges.

Solara Active Pharma Sciences Investor Presentation: Key Takeaways

Solara's Q2 FY27 delivered record EBITDA and PAT in five years, driven by 33% revenue growth. Base business strength offset Ibuprofen headwinds, which is now nearing breakeven.

Solara Active Pharma Sciences Employee Stock Options

Solara Active Pharma Sciences Limited allotted 8,300 equity shares under its 2018 ESOP plan. The exercise of these options realized Rs. 0.31 Crore for the company.

Value

₹0.31 Cr

Solara Active Pharma Sciences Q2 FY27 Results: Turns Profitable, Net Profit ₹28.5 Cr

Solara Active Pharma Sciences Ltd reported revenue from operations of ₹417.3 Cr (+33.1% YoY) and net profit of ₹28.5 Cr for Q2 FY27.

Key figure

Net profit ₹28.5 Cr

Solara Active Pharma Sciences Other Announcement

Solara Active Pharma received an ESG rating of 63 ('Strong' category) from Crisil ESG Ratings for the fiscal year 2026, an upgrade from the prior year.

Pace Digitek Results Update

Pace Digitek reported Q2 FY27 revenue of Rs 808 crore, up 51.5% YoY. FY27 revenue guidance was raised to Rs 3,300–3,500 crore.

Kirloskar Industries Results Update

Kirloskar Industries forwarded its material subsidiary KFIL's unaudited Q2 FY27 results press release. KFIL reported 17% revenue growth to Rs 2,047 Crore.

DMCC Speciality Chemicals Results Update

DMCC Speciality Chemicals reported Q2FY27 revenue of Rs 272.88 Crore, up 116.51% year-on-year. Profit after tax fell to Rs 3.23 Crore amid elevated sulphur prices.

Aurionpro Solutions Results Update

Aurionpro Solutions reported record Q2 FY27 revenue of ₹415 Cr, up 16% YoY, with a ₹2,050 Cr order book. The press release also lists new wins, go-lives and an earnings call on 2 November 2026.

Order book

₹2,050 Cr

Quality Power Electrical Equipments Results Update

Quality Power Electrical Equipments reported Q2 FY27 revenue of Rs. 294 Cr, up 34.1%. H1 PAT rose 52.4% to Rs. 110 Cr.

Order book

₹2,010 Cr

Rainbow Childrens Medicare Results Update

Rainbow Children's Medicare reported Q2 FY27 revenue of Rs. 5,480 Mn, up 23% YoY, with PAT of Rs. 839 Mn. Nellore and Guntur hospitals commenced operations during the quarter.

hospital beds

120.0 beds